Related Experiment Video
Updated: Dec 25, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Multiple Cranial Nerve Blocks as an Alternative Preventative Therapy for Chronic Migraine
Linford Fernandes1, Nashaba Khan1, Jessica Dobson1
1Department of Neurology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Repetitive multiple cranial nerve blocks (MCNBs) show promise in preventing chronic migraine, reducing headache days and improving patient-reported outcomes. This study suggests MCNBs can be an effective preventative therapy for chronic migraine sufferers.
Area of Science:
- Neurology
- Pain Management
Background:
- Multiple cranial nerve blocks (MCNBs), including greater occipital nerve (GON) blocks, are utilized for acute migraine treatment.
- Limited evidence exists regarding the efficacy of repeated MCNBs for chronic migraine prevention.
Purpose of the Study:
- To evaluate the effectiveness of multiple cranial nerve blocks (MCNBs) as a preventative therapy for chronic migraine.
Main Methods:
- A prospective cohort study involving 64 chronic migraine patients treated between June 2017 and March 2019.
- Data collected included demographic information, reduction in headache days, Headache Impact Test 6 (HIT6) scores, and patient-reported effectiveness.
- Patients received either occipital nerve blocks alone or combined occipital and trigeminal nerve blocks.
Main Results:
- A mean reduction of 5.4 headache days and 5.3 points in HIT6 scores was observed post-MCNBs.
- 66% of patients experienced at least a 30% reduction in headache days, with an average duration of effect of 5.7 weeks.
- 13 patients transitioned to low-frequency episodic migraine, while 34% showed no significant improvement.
Conclusions:
- Repetitive MCNBs can be an effective preventative strategy for patients suffering from chronic migraine.
- The study supports the use of MCNBs for long-term management of chronic migraine.
- Minor complications were infrequent, occurring in 8% of injections.
Related Concept Videos
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Depolarizing Blockers: Pharmocokinetics
Drugs Acting on Autonomic Ganglia: Blockers
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Skeletal Muscle Relaxants: Therapeutic Uses
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...

